Larry W. Markham

3.4k total citations
74 papers, 1.4k citations indexed

About

Larry W. Markham is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Larry W. Markham has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 44 papers in Cardiology and Cardiovascular Medicine and 21 papers in Epidemiology. Recurrent topics in Larry W. Markham's work include Muscle Physiology and Disorders (39 papers), Cardiomyopathy and Myosin Studies (32 papers) and Congenital Heart Disease Studies (18 papers). Larry W. Markham is often cited by papers focused on Muscle Physiology and Disorders (39 papers), Cardiomyopathy and Myosin Studies (32 papers) and Congenital Heart Disease Studies (18 papers). Larry W. Markham collaborates with scholars based in United States, Japan and Canada. Larry W. Markham's co-authors include Linda Cripe, D. Woodrow Benson, Brenda Wong, Jonathan H. Soslow, Kathi Kinnett, W. Bryan Burnette, David Parra, Kan N. Hor, Philip R. Khoury and James C. Slaughter and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Larry W. Markham

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry W. Markham United States 20 894 877 178 174 166 74 1.4k
Elizabeth Wraige United Kingdom 19 177 0.2× 394 0.4× 127 0.7× 335 1.9× 134 0.8× 51 1.2k
Frederik J. de Lange Netherlands 20 1.1k 1.2× 610 0.7× 778 4.4× 310 1.8× 237 1.4× 51 1.9k
Attilio Odero Italy 17 1.2k 1.3× 382 0.4× 344 1.9× 89 0.5× 372 2.2× 42 1.7k
Derek K. Smith United States 19 103 0.1× 745 0.8× 180 1.0× 79 0.5× 121 0.7× 48 1.3k
Karlien Mul Netherlands 17 185 0.2× 541 0.6× 108 0.6× 40 0.2× 25 0.2× 53 802
James Hong Canada 18 136 0.2× 268 0.3× 242 1.4× 68 0.4× 83 0.5× 42 897
R. Scalco United Kingdom 15 163 0.2× 543 0.6× 422 2.4× 69 0.4× 58 0.3× 66 1.2k
Sandro Beretta Italy 16 232 0.3× 142 0.2× 123 0.7× 42 0.2× 111 0.7× 27 721
Emmanuelle Salort‐Campana France 21 97 0.1× 251 0.3× 75 0.4× 142 0.8× 28 0.2× 68 1.0k
Joseph A. Shrader United States 19 78 0.1× 448 0.5× 250 1.4× 430 2.5× 37 0.2× 38 1.3k

Countries citing papers authored by Larry W. Markham

Since Specialization
Citations

This map shows the geographic impact of Larry W. Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry W. Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry W. Markham more than expected).

Fields of papers citing papers by Larry W. Markham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry W. Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry W. Markham. The network helps show where Larry W. Markham may publish in the future.

Co-authorship network of co-authors of Larry W. Markham

This figure shows the co-authorship network connecting the top 25 collaborators of Larry W. Markham. A scholar is included among the top collaborators of Larry W. Markham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry W. Markham. Larry W. Markham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Starnes, Joseph R., Xu Meng, Kristen George‐Durrett, et al.. (2024). Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy. Journal of the American Heart Association. 13(9). e032960–e032960. 1 indexed citations
2.
George‐Durrett, Kristen, Kimberly Crum, James C. Slaughter, et al.. (2023). Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 25(1). 44–44. 3 indexed citations
3.
Soslow, Jonathan H., Meng Xu, James C. Slaughter, et al.. (2023). Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy. Circulation Heart Failure. 16(8). e010040–e010040. 12 indexed citations
4.
Nasr, Viviane G., Larry W. Markham, James A. DiNardo, et al.. (2022). Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association. Circulation Cardiovascular Quality and Outcomes. 16(1). e000113–e000113. 12 indexed citations
5.
Starnes, Joseph R., Kimberly Crum, Kristen George‐Durrett, et al.. (2022). Novel Cardiac Imaging Risk Score for Mortality Prediction in Duchenne Muscular Dystrophy. Pediatric Cardiology. 45(6). 1221–1231. 4 indexed citations
6.
Raucci, Frank J., Meng Xu, Kristen George‐Durrett, et al.. (2021). Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy. Journal of Cardiovascular Magnetic Resonance. 23(1). 48–48. 11 indexed citations
7.
Raucci, Frank J., et al.. (2021). Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies. Pediatric Research. 92(6). 1613–1620. 8 indexed citations
8.
Pemberton, Victoria L., Nicholas Dagincourt, Danielle Hollenbeck-Pringle, et al.. (2020). Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network’s Marfan Trial experience. Clinical Trials. 17(6). 684–695. 4 indexed citations
9.
Raucci, Frank J., Anand Prakash Singh, Jonathan H. Soslow, et al.. (2020). The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy. International Journal of Molecular Sciences. 21(20). 7466–7466. 8 indexed citations
10.
Donnelly, Thomas E., Kimberly Crum, Larry W. Markham, et al.. (2020). Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 7(3). 331–342. 21 indexed citations
11.
Soslow, Jonathan H., Meng Xu, James C. Slaughter, et al.. (2019). The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy. Journal of Cardiac Failure. 25(4). 259–267. 23 indexed citations
12.
Chu, Patricia Y., et al.. (2018). PHENOTYPIC CLASSIFICATION OF FONTAN FAILURE: AN INDICATOR OF CLINICAL OUTCOME. Journal of the American College of Cardiology. 71(11). A535–A535. 1 indexed citations
13.
Markham, Larry W., Candice Brinkmeyer‐Langford, Jonathan H. Soslow, et al.. (2017). GRMD cardiac and skeletal muscle metabolism gene profiles are distinct. BMC Medical Genomics. 10(1). 21–21. 9 indexed citations
14.
Murphy, Lexa K., Bruce E. Compas, Kristen L. Reeslund, et al.. (2015). Cognitive and attentional functioning in adolescents and young adults with Tetralogy of Fallot and d-transposition of the great arteries. Child Neuropsychology. 23(1). 99–110. 17 indexed citations
15.
Markham, Larry W.. (2014). Update on the challenges facing the adult with congenital heart disease community. Current Opinion in Pediatrics. 26(5). 521–526. 2 indexed citations
16.
Hor, Kan N., Janaka Wansapura, Larry W. Markham, et al.. (2009). Circumferential Strain Analysis Identifies Strata of Cardiomyopathy in Duchenne Muscular Dystrophy. Journal of the American College of Cardiology. 53(14). 1204–1210. 143 indexed citations
17.
Zárate, Yuri A., Larry W. Markham, Linda Cripe, et al.. (2007). Novel Fibrillin 1 Mutation in a Case of Neonatal Marfan Syndrome: The Increasing Importance of Early Recognition. Congenital Heart Disease. 2(5). 342–346. 16 indexed citations
18.
Graham, T.P., Larry W. Markham, David Parra, & David P. Bichell. (2007). Congenitally corrected transposition of the great arteries: An update. Current Treatment Options in Cardiovascular Medicine. 9(5). 407–413. 13 indexed citations
19.
Cripe, Linda, Brent J. Barber, Robert L. Spicer, et al.. (2006). Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy. Neuromuscular Disorders. 16(11). 745–748. 11 indexed citations
20.
Markham, Larry W., R. Spicer, Philip R. Khoury, et al.. (2005). Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy. Pediatric Cardiology. 26(6). 768–771. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Wraige Breakdown of academic impact, for papers by Frederik J. de Lange Breakdown of academic impact, for papers by Attilio Odero Breakdown of academic impact, for papers by Derek K. Smith Breakdown of academic impact, for papers by Karlien Mul Breakdown of academic impact, for papers by James Hong Breakdown of academic impact, for papers by R. Scalco Breakdown of academic impact, for papers by Sandro Beretta Breakdown of academic impact, for papers by Emmanuelle Salort‐Campana Breakdown of academic impact, for papers by Joseph A. Shrader
Rankless by CCL
2026